Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Margaret Callahan
Evaluation of the Immunologic Impact of RAF Inhibitors to Guide Optimal Combination of RAF Inhibitors and Immunotherapy for the Treatment of Advanced Melanoma
Related publications
AurkA Inhibitors Enhance the Effects of B-Raf and MEK Inhibitors in Melanoma Treatment
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Effects of RAF Inhibitors on PI3K/AKT Signalling Depend on Mutational Status of the RAS/RAF Signalling Axis
Oncotarget
Oncology
A New B-Raf Inhibitor Combo for Advanced Melanoma
Oncotarget
Oncology
HDAC Inhibitors Enhance the Immunotherapy Response of Melanoma Cells
Oncotarget
Oncology
Next-Generation RAF Inhibitors Prevent Paradoxical MAPK Activation
Cancer Discovery
Oncology
The Combination of Novel Low Molecular Weight Inhibitors of RAF (LBT613) and Target of Rapamycin (RAD001) Decreases Glioma Proliferation and Invasion
Molecular Cancer Therapeutics
Cancer Research
Oncology
RAF Dimer Inhibition Enhances the Antitumor Activity of MEK Inhibitors in K‐RAS Mutant Tumors
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Tumour Micro-Environment Elicits Innate Resistance to RAF Inhibitors Through HGF Secretion
Nature
Multidisciplinary
Azologization of a Hetero-Stilbene Based C-Raf Kinase Inhibitor: Towards the Design of Photoswitchable Sirtuin Inhibitors
